Company intelligence / Profile preview

Ponte Biosciences

Rochester, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Ponte Biosciences develops the Spheroid Reservoir Bioartificial Liver System, a cell-based device designed to temporarily replace or supplement failing livers in ICU patients with acute or advanced liver failure. The technology uses metabolically active primary hepatocytes and was developed at Mayo Clinic. The company remains preclinical but recently won funding and recognition for its innovation at Medtech MVP in June 2024.

Therapeutic areas: Gastroenterology
Modalities: Cell therapyDevice
Industry: Therapeutic Medical Devices

Partnerships

Mayo Clinic

Beyond the preview

Go deeper on Ponte Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ponte Biosciences.

Explore the full profile